• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低分子量硫酸化壳寡糖抗 HIV-1 活性的研究。

Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides.

机构信息

Department of Chemistry, Pukyong National University, Busan 608-737, Republic of Korea.

出版信息

Carbohydr Res. 2010 Mar 30;345(5):656-62. doi: 10.1016/j.carres.2009.12.017. Epub 2009 Dec 23.

DOI:10.1016/j.carres.2009.12.017
PMID:20117763
Abstract

Chitooligosaccharides are nontoxic and water-soluble compounds obtained by enzymatic degradation of chitosan, which is derived from chitin by a deacetylation process. Chitooligosaccharides possess broad range of activities such as antitumour, antifungal, antibacterial activities. Sulfated chitooligosaccharides (SCOSs) with different molecular weights were synthesized by a random sulfation reaction. In the present study, anti-HIV-1 properties of SCOSs and the impact of molecular weight on their inhibitory activity were investigated. SCOS III (MW 3-5 kDa) was found to be the most effective compound to inhibit HIV-1 replication. At nontoxic concentrations, SCOS III exhibited remarkable inhibitory activities on HIV-1-induced syncytia formation (EC(50) 2.19 microg/ml), lytic effect (EC(50) 1.43 microg/ml), and p24 antigen production (EC(50) 4.33 microg/ml and 7.76 microg/ml for HIV-1(RF) and HIV-1(Ba-L), respectively). In contrast, unsulfated chitooligosaccharides showed no activity against HIV-1. Furthermore, it was found that SCOS III blocked viral entry and virus-cell fusion probably via disrupting the binding of HIV-1 gp120 to CD4 cell surface receptor. These results suggest that sulfated chitooligosaccharides represent novel candidates for the development of anti-HIV-1 agent.

摘要

壳寡糖是通过壳聚糖的酶解得到的无毒水溶性化合物,壳聚糖是通过脱乙酰过程从几丁质中获得的。壳寡糖具有广泛的活性,如抗肿瘤、抗真菌、抗菌活性。不同分子量的硫酸化壳寡糖(SCOSs)通过随机硫酸化反应合成。在本研究中,研究了 SCOSs 的抗 HIV-1 特性及其分子量对其抑制活性的影响。发现 SCOS III(MW 3-5 kDa)是抑制 HIV-1 复制最有效的化合物。在非毒性浓度下,SCOS III 对 HIV-1 诱导的合胞体形成(EC(50)2.19 μg/ml)、裂解作用(EC(50)1.43 μg/ml)和 p24 抗原产生(EC(50)4.33 μg/ml 和 7.76 μg/ml,用于 HIV-1(RF)和 HIV-1(Ba-L))表现出显著的抑制活性。相比之下,未硫酸化的壳寡糖对 HIV-1 没有活性。此外,研究发现 SCOS III 通过破坏 HIV-1 gp120 与 CD4 细胞表面受体的结合,阻断病毒进入和病毒-细胞融合。这些结果表明,硫酸化壳寡糖是开发抗 HIV-1 药物的新型候选物。

相似文献

1
Anti-HIV-1 activity of low molecular weight sulfated chitooligosaccharides.低分子量硫酸化壳寡糖抗 HIV-1 活性的研究。
Carbohydr Res. 2010 Mar 30;345(5):656-62. doi: 10.1016/j.carres.2009.12.017. Epub 2009 Dec 23.
2
Sulfated chitooligosaccharides as prolyl endopeptidase inhibitor.硫酸化壳寡糖作为脯氨酰内肽酶抑制剂。
Int J Biol Macromol. 2007 Dec 1;41(5):529-33. doi: 10.1016/j.ijbiomac.2007.07.003. Epub 2007 Jul 17.
3
Soluble gC1q-R/p33, a cell protein that binds to the globular "heads" of C1q, effectively inhibits the growth of HIV-1 strains in cell cultures.可溶性gC1q-R/p33是一种能与C1q的球状“头部”结合的细胞蛋白,可有效抑制细胞培养中HIV-1毒株的生长。
Clin Immunol. 2001 May;99(2):222-31. doi: 10.1006/clim.2001.5013.
4
Novel, negatively charged, human serum albumins display potent and selective in vitro anti-human immunodeficiency virus type 1 activity.新型带负电荷的人血清白蛋白在体外显示出强大且具有选择性的抗1型人类免疫缺陷病毒活性。
Mol Pharmacol. 1993 Nov;44(5):1003-7.
5
Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4.鉴定N-苯基-N'-(2,2,6,6-四甲基哌啶-4-基)草酰胺为一类新型的HIV-1进入抑制剂,其可阻止gp120与CD4结合。
Virology. 2005 Sep 1;339(2):213-25. doi: 10.1016/j.virol.2005.06.008.
6
An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step.一种包含env前体切割区域的抗人类免疫缺陷病毒多抗原肽在CD4结合后步骤干扰膜融合。
Virology. 2000 Jul 20;273(1):169-77. doi: 10.1006/viro.2000.0368.
7
A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.一种对艾滋病相关机会性微生物具有治疗活性的杀伤性模拟表位可抑制离体HIV-1复制。
AIDS. 2006 Apr 24;20(7):975-80. doi: 10.1097/01.aids.0000222068.14878.0d.
8
New bis(thiosemicarbazonate) gold(III) complexes inhibit HIV replication at cytostatic concentrations: potential for incorporation into virostatic cocktails.新型双(硫代氨基甲酸盐)金(III)配合物在细胞毒性浓度下抑制 HIV 复制:整合入抗病毒鸡尾酒疗法的潜力。
J Inorg Biochem. 2011 Sep;105(9):1173-80. doi: 10.1016/j.jinorgbio.2011.05.011. Epub 2011 May 26.
9
Multiple and multivalent interactions of novel anti-AIDS drug candidates, sulfated polymannuronate (SPMG)-derived oligosaccharides, with gp120 and their anti-HIV activities.新型抗艾滋病候选药物硫酸化聚甘露糖醛酸(SPMG)衍生寡糖与gp120的多重及多价相互作用及其抗HIV活性。
Glycobiology. 2005 May;15(5):501-10. doi: 10.1093/glycob/cwi031. Epub 2004 Dec 22.
10
Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.通过表达融合蛋白VPR-抗整合酶单链可变片段(SFv)抑制HIV-1复制和感染性:病毒内分子疗法
J Hum Virol. 2000 Jan-Feb;3(1):6-15.

引用本文的文献

1
Bird's eye view of natural products for the development of new anti-HIV agents: Understanding from a therapeutic viewpoint.从治疗角度理解用于开发新型抗HIV药物的天然产物:鸟瞰视角
Animal Model Exp Med. 2025 Mar;8(3):441-457. doi: 10.1002/ame2.12563. Epub 2025 Feb 7.
2
In Vitro Anti-HIV-1 Activity of Fucoidans from Brown Algae.体外抗 HIV-1 活性的褐藻岩藻聚糖。
Mar Drugs. 2024 Jul 31;22(8):355. doi: 10.3390/md22080355.
3
Phospho-Chitooligosaccharides below 1 kDa Inhibit HIV-1 Entry In Vitro.低于1千道尔顿的磷酸化壳寡糖在体外抑制HIV-1进入。
Curr Issues Mol Biol. 2024 Apr 22;46(4):3729-3740. doi: 10.3390/cimb46040232.
4
Chitooligosaccharide and Its Derivatives: Potential Candidates as Food Additives and Bioactive Components.壳寡糖及其衍生物:作为食品添加剂和生物活性成分的潜在候选物。
Foods. 2023 Oct 20;12(20):3854. doi: 10.3390/foods12203854.
5
Proteome Analysis of the Antiproliferative Activity of the Novel Chitooligosaccharide-Gallic Acid Conjugate against the SW620 Colon Cancer Cell Line.新型壳寡糖-没食子酸共轭物对SW620结肠癌细胞系抗增殖活性的蛋白质组学分析
Biomedicines. 2023 Jun 10;11(6):1683. doi: 10.3390/biomedicines11061683.
6
Anti-COVID-19 Credentials of Chitosan Composites and Derivatives: Future Scope?壳聚糖复合材料及衍生物的抗COVID-19特性:未来前景如何?
Antibiotics (Basel). 2023 Mar 28;12(4):665. doi: 10.3390/antibiotics12040665.
7
In Vitro Anti-HIV-1 Activity of Chitosan Oligomers -Conjugated with Asparagine and Glutamine.与天冬酰胺和谷氨酰胺共轭的壳寡糖的体外抗HIV-1活性
BioTech (Basel). 2023 Feb 8;12(1):18. doi: 10.3390/biotech12010018.
8
Bactericidal Action of Shrimp Shell Chitooligosaccharide Conjugated with Epigallocatechin Gallate (COS-EGCG) against .虾壳壳寡糖与表没食子儿茶素没食子酸酯共轭物(COS-EGCG)对……的杀菌作用
Foods. 2023 Feb 2;12(3):634. doi: 10.3390/foods12030634.
9
An overview of fungal chitinases and their potential applications.真菌几丁质酶概述及其潜在应用。
Protoplasma. 2023 Jul;260(4):1031-1046. doi: 10.1007/s00709-023-01839-5. Epub 2023 Feb 8.
10
Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs.纳米技术在抗击 COVID-19 中的应用:从创新纳米材料到计算机辅助发现潜在的抗病毒植物衍生药物。
Biomolecules. 2022 Jul 30;12(8):1060. doi: 10.3390/biom12081060.